EUVIMEDObjevte EUVIMED
Open access

Endothelial CD44 cleavage by ADAM17 impairs shear stress mechanotransduction

Gavin Power iD, Min Jeong Cho, Jesus H Beltran-Ornelas, Marc A Augenreich iD, Natnicha Imkaew, Olubodun M Lateef, Francisco I Ramirez-Perez iD, Larissa Ferreira-Santos iD, Camila Manrique-Acevedo, Luis A Martinez-Lemus iD, Jaume Padilla iD

Function · 2026-06-01 · 7 (3)

DOI: 10.1152/function.113.2025 ↗

At a glance

Journal article in Function, published on 2026-06-01. Written by Gavin Power and 10 co-authors. Institution: NextGen Precision Health, University of Missouri, Columbia, Missouri, United States. Major MEDLINE topics: ADAM17 Protein, Hyaluronan Receptors, Mechanotransduction, Cellular, Diabetes Mellitus, Type 2. Cited 5 times so far (Crossref); 40 references. The full text is freely available in PubMed Central. Funded by: NIH HHS, Veterans Affairs Merit, American Heart Association.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Impaired flow-mediated dilation (FMD) is an indicator of endothelial dysfunction in type 2 diabetes (T2D). However, the exact cellular and molecular mechanisms contributing to impaired mechanotransduction of shear stress in T2D are incompletely understood. This work supports the novel concept that increased endothelial activity of a disintegrin and metalloproteinase 17 (ADAM17) causes cleavage of cell-surface CD44, leading to loss of hyaluronan (HA)-associated shear stress mechanotransduction.

Subjects

MeSH terms (MEDLINE)

ADAM17 ProteinHyaluronan ReceptorsMechanotransduction, CellularDiabetes Mellitus, Type 2Endothelium, VascularHumansAnimalsStress, MechanicalMaleFemaleHyaluronic AcidMiceVasodilationMiddle Aged

Author keywords

ADAM17CD44endothelial dysfunctionshear stress mechanotransductiontype 2 diabetes

Substances

ADAM17 ProteinHyaluronan ReceptorsADAM17 protein, humanHyaluronic AcidCD44 protein, humanAdam17 protein, mouse

Authors and institutions

  • NextGen Precision Health, University of Missouri, Columbia, Missouri, United States.
  • Department of Nutrition and Exercise Physiology, University of Missouri, Columbia, Missouri, United States.
  • Department of Medical Pharmacology and Physiology, University of Missouri, Columbia, United States.
  • Instituto do Coração (InCor), Hospital das Clínicas HCFMUSP, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
  • Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Missouri, Columbia, Missouri, United States.
  • Harry S. Truman Memorial Veteran's Hospital, Columbia, Missouri, United States.

ORCID profiles: Gavin Power, Marc A Augenreich, Francisco I Ramirez-Perez, Larissa Ferreira-Santos, Luis A Martinez-Lemus, Jaume Padilla

Funding

  • NIH HHS
  • Veterans Affairs Merit
  • American Heart Association
  • São Paulo Research Foundation
  • FAPESP
  • NHLBI NIH HHS
  • National Institutes of Health

Cite

APA

Power, G., Cho, M. J., Beltran-Ornelas, J. H., Augenreich, M. A., Imkaew, N., Lateef, O. M., Ramirez-Perez, F. I., Ferreira-Santos, L., Manrique-Acevedo, C., Martinez-Lemus, L. A., & Padilla, J. (2026). Endothelial CD44 cleavage by ADAM17 impairs shear stress mechanotransduction. Function, 7(3). https://doi.org/10.1152/function.113.2025

Vancouver

Power G, Cho MJ, Beltran-Ornelas JH, Augenreich MA, Imkaew N, Lateef OM, et al. Endothelial CD44 cleavage by ADAM17 impairs shear stress mechanotransduction. Function. 2026;7(3). doi:10.1152/function.113.2025

BibTeX
@article{Power2026,
  author = {Power, Gavin and Cho, Min Jeong and Beltran-Ornelas, Jesus H and Augenreich, Marc A and Imkaew, Natnicha and Lateef, Olubodun M and Ramirez-Perez, Francisco I and Ferreira-Santos, Larissa and Manrique-Acevedo, Camila and Martinez-Lemus, Luis A and Padilla, Jaume},
  title = {Endothelial CD44 cleavage by ADAM17 impairs shear stress mechanotransduction},
  journal = {Function},
  year = {2026},
  volume = {7},
  number = {3},
  doi = {10.1152/function.113.2025}
}
Start for free →